WASHINGTON (Reuters) - U.S. President-elect Donald Trump is expected to select Robert F. Kennedy Jr. to lead the Department ...

Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and ...

Polen Capital, an investment management company, released its “Polen Global Growth Strategy” third-quarter 2024 investor ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.

Ozempic and related GLP-1 drugs have taken Europe and North America by storm and have quickly become the darling of the ...

Robert F. Kennedy Jr., an environmental and anti-vaccine activist, was selected by President-elect Donald Trump to lead the ...

In a post on X, Kennedy vowed to work to end chronic disease, clean up corruption and provide Americans with the data they ...

Key Takeaways Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's ...

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.'s latest push into healthcare will disrupt Hims & Hers' business.